Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial

ABSTRACT:

SUBMITTER: Fang W 

PROVIDER: S-EPMC12139608 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature